Skip to main content
NTRNutrien Ltd.Hold6.0·$60.40-1.85%
NTR · Why this verdict

Why Nutrien (NTR) is rated HOLD

Updated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

VerdictHOLD
Overall score6.0/10
ConfidenceMEDIUM
MacroNEUTRAL
TrendMatrix Research · core thesis

Engine thesis — one sentence

Nutrien is under a tender offer with upside capped at the deal spread, offering a forward price-to-earnings of 12.3x and attractively valued metrics, but faces consecutive earnings misses, elevated put/call ratio of 2.34, and below-average quality score of 4.4, making the investment thesis primarily event-driven around the M&A outcome.

Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.

Thesis pillars

Nutrien is currently the subject of a tender offer, making the near-term investment thesis primarily dependent on the deal completing at the offered price versus the downside risk if the deal fails and the stock re-prices to its standalone intrinsic value.

Stable
Warnings
Expectation
The tender offer completes at or above the implied deal price within 12 months, delivering the deal spread to investors who bought below the deal price.

CounterM&A deals in the agricultural inputs sector can be disrupted by antitrust review, financing conditions, or commodity price swings that alter the strategic rationale for the acquirer.

On a standalone basis, Nutrien trades at a forward price-to-earnings ratio of 12.3x and a PEG ratio of 1.21, placing it in the attractively valued category for agricultural inputs and providing a valuation floor in a deal-failure scenario.

Stable
Valuation breakdown
Expectation
Standalone forward price-to-earnings ratio remains below 15x on consensus estimates if the tender offer does not complete, limiting downside to deal-failure scenarios.

CounterTwo consecutive earnings misses suggest that consensus estimates may be too high, meaning the apparent low multiple could expand if estimates are revised downward following deal uncertainty.

Nutrien has missed analyst earnings estimates in 2 consecutive quarters with misses of -7.0% and -8.55%, indicating that fertilizer market conditions are running below analyst expectations.

Stable
Bear case
Expectation
The company returns to beating or meeting earnings estimates in at least 2 of the next 4 quarters as potash and nitrogen pricing stabilizes.

CounterThe company beat in 2 of the prior 4 quarters as well, suggesting cyclical volatility in earnings delivery is normal for an agricultural inputs producer tied to commodity price cycles.

The put/call ratio of 2.34 is elevated, indicating the options market is positioning for downside protection, likely reflecting uncertainty around the M&A deal outcome and deal failure risk.

Stable
Key risks
Expectation
Put/call ratio declines below 1.2 within 12 months as deal certainty increases or the situation resolves — either through deal completion or price re-rating.

CounterElevated put/call ratios during M&A situations are often mechanical, with arbitrageurs buying puts as a hedge against long stock positions rather than expressing directional bearish views.

Per-dimension breakdown

Value

7.9/10data confidence 100%
ComponentSub-score
P/E8.5
P/S9.6
EV/EBITDA7.3
Fwd P/E9.1
PEG6.2
Analyst target7.5
  • Forward P/E: 11.5x
  • PEG: 1.21
  • Attractively valued

Quality

4.4/10data confidence 100%
ComponentSub-score
ROE3.3
ROA2.8
Gross margin2.5
Op margin2.6
Net margin4.4
Current ratio4.7
FCF quality5.2
Moat5.6
Piotroski F8.9
  • Earnings quality warning: 67% FCF/NI
  • Strong Piotroski F-Score: 8/9

Growth

7.3/10data confidence 33%
ComponentSub-score
Rev growth7.3

Momentum

2.5/10data confidence 100%
ComponentSub-score
RSI3.0
MACD0.0
OBV1.0
MA position2.2
Volume6.5
  • Capitulation risk (RSI 20, below 200MA)
  • Volume distribution (falling OBV)
  • Below 200-MA but MA still rising (+2.6%/30d) — pullback in uptrend, not confirmed weakness

Sentiment

7.5/10data confidence 100%
ComponentSub-score
LLM sentiment6.2
Analyst rating7.5
Price target8.9
  • Analyst upside: 35%

Insider

5.0/10data confidence 50%

Peer rank

5.5/10data confidence 80%
ComponentSub-score
value rank4.7
quality rank6.0
growth rank6.3

Technical

7.5/10data confidence 100%
ComponentSub-score
bollinger10.0
support resistance9.9
52w position4.2
gap6.0

Risk (lower is worse)

7.6/10data confidence 100%
ComponentSub-score
short interest9.7
days to cover10.0
volatility6.0
put call9.4
implied vol5.8
beta6.8
debt equity7.7
news risk5.5

Catalyst

4.7/10data confidence 100%
ComponentSub-score
erm6.0
earnings history3.3
earnings timing5.0
surprise avg1.9
dividend safety6.0
news activity6.0
  • Earnings concerns: 2B/2M
  • Dividend: 357.0%

How the verdict was assembled

Engine trigger

Mixed signals. Hold existing position.

Engine technical detail
verdict_path: L4:PATH_F_HOLD_DEFAULT
Passed (7)
  • ASYMMETRY:4.1>=1.5
  • INSIDER:OK
  • 8K:CLEAN
  • NEWS_EVENTS:NONE_RECENT
  • EARNINGS_PROXIMITY:42d clear
  • SEMI_CYCLE_PEAK:CLEAR
  • MATERIALS_CYCLE_PEAK:CLEAR
Failed (1)
  • MOMENTUM:2.5<4.5
Warning (0)

none

Reward-to-Risk
4.11
Upside
+21.5%
Downside
5.2%
Sizing output
AVOID

SetupOVERSOLD_BOUNCE Oversold RSI 20, near Bollinger lower, volume surge

EdgeNO_EDGE No clear edge identified

SuitabilityMODERATE Balanced profile

Investment implication

The default F-path HOLD fired without any positive-conviction gate triggering — no momentum acceleration, no quality+value crossover, no setup recognition. Highest-clear gate: ASYMMETRY:4.1>=1.5. Top dim: Value at 7.9; weakest: Momentum at 2.5. The engine's read is one of pattern absence — no directional conviction in either direction at current asymmetry.

The strongest dimensions are Value at 7.9, Risk (lower is worse) at 7.6, and Sentiment at 7.5; the weakest are Momentum at 2.5, Quality at 4.4, and Catalyst at 4.7. The V9 engine flagged 1 failed gate, producing an asymmetric reward-to-risk of 4.11 and an engine sizing output of AVOID.

What would invalidate the thesis

Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.

  • P1Nutrien is currently the subject of a tender offer, making the near-term investment thesis primarily dependent on the deal completing at the offered price versus the downside risk if the deal fails and the stock re-prices to its standalone intrinsic value.

    Trip ifThe tender offer is terminated or withdrawn, causing the stock to fall below $58.

  • P2On a standalone basis, Nutrien trades at a forward price-to-earnings ratio of 12.3x and a PEG ratio of 1.21, placing it in the attractively valued category for agricultural inputs and providing a valuation floor in a deal-failure scenario.

    Trip ifForward price-to-earnings ratio rises above 18x as consensus earnings estimates decline below $3.50 per share.

  • P3Nutrien has missed analyst earnings estimates in 2 consecutive quarters with misses of -7.0% and -8.55%, indicating that fertilizer market conditions are running below analyst expectations.

    Trip ifEPS surprise falls below -10% in at least 2 of the next 4 quarters.

  • P4The put/call ratio of 2.34 is elevated, indicating the options market is positioning for downside protection, likely reflecting uncertainty around the M&A deal outcome and deal failure risk.

    Trip ifPut/call ratio rises above 4.0 or the deal spread widens to more than 15% below the deal price.

Engine reasoning is mechanically derived from pipeline gate outputs. See decision view.

Home Stocks NTR Why this verdict